Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 50,000 FDMT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 50,000 | n/a |
| Apr 27, 2026 | AMICUS THERAPEUTICS, INC. (FOLD) | Disposition to Issuer | 142,564 | $2.07M |
| Feb 21, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 6,200 | n/a |
| Jan 8, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 45,000 | n/a |
| Jun 6, 2025 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/Award | 20,414 | n/a |
| Feb 24, 2025 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 32,900 | n/a |
| Jun 7, 2024 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/Award | 11,847 | n/a |
| May 23, 2024 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 22,000 | n/a |
| Mar 11, 2024 | AMICUS THERAPEUTICS, INC. (FOLD) | Exercise/Conversion | 15,000 | $42.0K |
| Sep 14, 2023 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 44,000 | n/a |